Hydroxychloroquine – New Evidence for Better Pregnancy Outcomes in APS
Aya Berman, Family medicine resident at Clalit Health Services, shared a post on LinkedIn:
“Thrilled to share our new study: ‘Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis” is now published in RMD Open.
This study represents a meaningful step in understanding the role of hydroxychloroquine in improving obstetric outcomes for patients with antiphospholipid syndrome.
The findings were first presented by Dr. Orly Efros at the International Society on Thrombosis and Haemostasis (ISTH) Annual Congress in Bangkok, and I am delighted that the full manuscript is now available here.
Grateful to my colleagues and collaborators for their dedication and contributions that made this work possible!
Orly Efros, Gili Kenet, Aharon lubetsky, Nancy Agmon-Levin, Shelly Soffer, MD, assaf barg, Sarina Levy mendelovich, omri cohen, Liat Waldman Radinsky, Shadan Lalezari, Eyal Klang”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly